Taken together, we demonstrated that Rb1 facilitated renal angiogenesis by activating the VEGFR2/AKT pathway of endothelial cells, thereby arresting the transition from AKI to CKD, and providing a potential therapeutic strategy for AKI. The gene discussed is KDR; the disease is chronic kidney disease.